MetLife offers three exchange-traded preferred stocks, providing investors with diversification beyond bank issuers. Read ...
With its European and Chinese partners, Kiwi drug minnow AFT Pharmaceuticals plans a 1000-patient trial of a novel iron ...
Entrada Therapeutics reported a 3Q25 GAAP EPS loss of –$1.06 and revenue of $1.6 million, reflecting declining collaboration ...
Sonder’s Chapter 7 bankruptcy and abrupt shutdown are creating disruption for landlords nationwide and raising new questions ...
Q3 2025 Earnings Call Transcript November 13, 2025 Omeros Corporation beats earnings expectations. Reported EPS is $-0.19, ...
Independent valuation reflects major advancement of OT-101 and Deciparticle™ nanomedicine platformSAN DIEGO, Nov. 20, 2025 (GLOBE NEWSWIRE) -- via IBN -- Oncotelic Therapeutics, Inc. (OTLC) today ...
The US Food and Drug Administration (FDA) has confirmed that Island Pharmaceuticals’ (ASX:ILA) antiviral candidate ...
Q3 2025 Earnings Call Transcript November 20, 2025 Nano-X Imaging Ltd. misses on earnings expectations. Reported EPS is ...
As late-stage biotech pipelines mature, fair-value remeasurements under U.S. Generally Accepted Accounting Principles (GAAP) are emerging as critical indicators of tangible scientific and commercial ...
Supposedly commercial air travel is back to normal, good for anyone coming in for the Mortgage Bankers Association of St. Louis event tomorrow and Thursday’s Mortgage Bankers Association of Kansas ...
Oncotelic Therapeutics, Inc. (OTLC) today announces that its joint venture partner, GMP Bio, has completed an independent third-party valuation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback